je.st
news
Tag: nordisk
Novo Nordisk diabetes drug fails to help heart failure: study
2015-11-09 01:18:18| Biotech - Topix.net
ORLANDO: The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday. The injectable drug, known chemically as liraglutide, was tested in 300 patients with and without type 2 diabetes who had advanced heart failure and a recent hospitalization.
Tags: study
heart
drug
failure
Novo Nordisk successfully completes diabetes drug phase 3a trial
2015-09-26 03:39:15| Biotech - Topix.net
Danish pharmaceutical company Novo Nordisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide, it said on Friday.
Tags: trial
drug
phase
successfully
Novo Nordisk adding diabetes drug output in NC, Denmark
2015-08-26 21:38:06| Biotech - Topix.net
Danish drug maker Novo Nordisk said Wednesday it will open new factories in North Carolina and Denmark as pharmaceutical companies seek to keep up with demand for diabetes medications in an increasingly overweight world. Novo Nordisk plans to invest about $2 billion over the next five years in new production facilities in the Raleigh suburb of Clayton and near Copenhagen, Denmark.
Tags: drug
output
adding
denmark
Premarket Biotech Digest: Is Gilead Undervalued, Oncolytics' Reolysin, Novo Nordisk Reports Results
2015-07-13 18:14:55| Biotech - Topix.net
Gilead Sciences shares have once again seen a pullback in the last three weeks. Since June 24th, the stock is down nearly 7%, presenting another good opportunity to buy.
Tags: results
reports
novo
digest
Novo Nordisk to end German sales of new insulin drug after price row
2015-07-01 20:23:39| Biotech - Topix.net
COPENHAGEN: Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy about the high cost of modern medicines.